Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Liposomal Injection Bupivacaine (Exparel) Superior to Standard Bupivacaine for Abdominoplasty? A Randomized Controlled Trial

NCT01853176 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01853176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01853176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Liposomal Injection Bupivacaine (Exparel) Superior to Standard Bupivacaine for Abdominoplasty? A Randomized Controlled Trial
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2013
Completion date
July 31, 2014
Enrollment
4 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative